Earnings History Data for Ironwood Pharmaceuticals, Inc. (IRWD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation and chronic constipation. The Company also focuses on one Phase 1 pain drug candidate and multiple preclinical programs, as well as on building a specialty biochemicals business based on a proprietary strain-development platform. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is headquartered in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		IRWD	Ironwood Pharmaceuticals, Inc.	717.23	0.02	0.09	0.12	Ironwood Pharmaceuticals Non-GAAP EPS of $0.02 misses by $0.08, revenue of $91.6M beats by $0.3M [11/7/2024 7:18 AM]	4.64	-0.40 (-7.84%)	4.65	-0.39 (-7.74%)	3.79 - 15.70	1,739,137	1,410,000	3,565
Ironwood Pharmaceuticals Q3 2024 Earnings Preview [11/6/2024 12:04 PM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.02 misses by $0.08, revenue of $91.6M beats by $0.3M [11/7/2024 7:18 AM] Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect [Nov-06-24 07:29AM] Ironwood Pharmaceuticals Reports Third Quarter 2024 Results [2024-11-07 07:00AM]
08-08-2024	PM		IRWD	Ironwood Pharmaceuticals, Inc.	964.87	N/A	0.17	0.31	Ironwood Pharmaceuticals Non-GAAP EPS of $0.00 misses by $0.14, revenue of $94.4M misses by $12.6M [8/8/2024 7:12 AM]	4.04	-1.97 (-32.86%)	6.32	0.31 (5.16%)	3.79 - 15.70	8,329,147	1,730,000	251
Ironwood Pharmaceuticals Q2 2024 Earnings Preview [8/7/2024 11:18 AM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.00 misses by $0.14, revenue of $94.4M misses by $12.6M [8/8/2024 7:12 AM]
09-05-2024	PM		IRWD	Ironwood Pharmaceuticals, Inc.	1,270	-0.02	0.18	0.25	Ironwood Pharmaceuticals Non-GAAP EPS of -$0.02 misses by $0.17, revenue of $74.88M misses by $30.82M [5/9/2024 7:20 AM]	6.75	-1.37 (-16.93%)	6.88	-1.24 (-15.29%)	6.21 - 15.70	6,174,038	2,510,000	52,318
Ironwood Pharmaceuticals Q1 2024 Earnings Preview [5/8/2024 11:21 AM] Ironwood Pharmaceuticals Non-GAAP EPS of -$0.02 misses by $0.17, revenue of $74.88M misses by $30.82M [5/9/2024 7:20 AM]
15-02-2024	PM		IRWD	Ironwood Pharmaceuticals, Inc.	2,370	N/A	0.20	0.27	Ironwood Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook [2/15/2024 7:13 AM]	15.01	-0.44 (-2.85%)	14.60	-0.85 (-5.50%)	8.07 - 15.70	4,039,715	3,280,000	12,633
Ironwood Pharmaceuticals Q4 2023 Earnings Preview [2/14/2024 2:13 PM] Ironwood Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook [2/15/2024 7:13 AM]
09-11-2023	PM		IRWD	Ironwood Pharmaceuticals, Inc.	1,470	0.12	0.17	0.28	Ironwood Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.04, revenue of $113.74M beats by $0.92M [11/9/2023 7:03 AM]	9.52	0.29 (3.14%)	9.36	0.13 (1.41%)	8.07 - 12.66	2,773,523	1,990,000	1,990
Ironwood Pharmaceuticals Q3 2023 Earnings Preview [11/8/2023 1:37 PM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.04, revenue of $113.74M beats by $0.92M [11/9/2023 7:03 AM] Jefferies starts Ironwood at buy, cites potential of drug apraglutide [11/9/2023 2:56 PM]
08-08-2023	PM		IRWD	Ironwood Pharmaceuticals, Inc.	1,730	0.31	0.25	0.21	Ironwood Pharmaceuticals reports mixed Q2 earnings; raises FY23 revenue outlook [8/8/2023 7:25 AM]	10.30	-1.04 (-9.21%)	11.50	0.15 (1.32%)	9.73 - 12.66	4,747,826	1,360,000	4,586
Ironwood Pharmaceuticals Q2 2023 Earnings Preview [8/7/2023 2:36 PM] Ironwood Pharmaceuticals reports mixed Q2 earnings; raises FY23 revenue outlook [8/8/2023 7:25 AM]
04-05-2023	PM	7:00 AM ET (May 4)	IRWD	Ironwood Pharmaceuticals, Inc.	1,610	0.25	0.24	0.21	Ironwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46M [5/4/2023 7:16 AM]	10.57	0.06 (0.62%)	10.10	-0.41 (-3.90%)	9.73 - 12.66	1,561,881	1,940,000	921
Ironwood Pharmaceuticals Q1 2023 Earnings Preview [5/3/2023 1:44 PM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46M [5/4/2023 7:16 AM]
16-02-2023	PM	7:00 AM ET (Feb 16)	IRWD	Ironwood Pharmaceuticals, Inc.	1,710	0.27	0.28	0.27	Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line [2/16/2023 7:06 AM]	11.36	0.16 (1.43%)	11.20	0.0 (0.00%)	9.73 - 12.95	1,358,913	1,930,000	866,990
Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line [2/16/2023 7:06 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	IRWD	Ironwood Pharmaceuticals, Inc.	1,710	0.28	0.27	0.33	Ironwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance [11/3/2022 7:18 AM]	11.40	0.44 (4.01%)	10.96	0.0 (0.00%)	9.73 - 13.23	1,298,224	1,650,000	33,432
Ironwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance [11/3/2022 7:18 AM] Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance [Nov-03-22 07:01AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	IRWD	Ironwood Pharmaceuticals, Inc.	1,810	0.21	0.31	0.34		11.48	0.28 (2.45%)	3.92	-0.40 (-9.26%)	10.13 - 14.27	1,915,046	2,860,000	51,552
Ironwood Pharmaceuticals Q2 2022 Earnings Preview [8/3/2022 12:57 PM] Ironwood Pharmaceuticals reports Q2 earnings miss; reaffirms FY22 guidance [8/4/2022 7:32 AM]
05-05-2022	PM	7:00 AM ET (May 5)	IRWD	Ironwood Pharmaceuticals, Inc.	1,880	0.21	0.27	0.24	Ironwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98M [5/5/2022 7:03 AM]	12.24	-0.16 (-1.29%)	12.40	0.0 (0.00%)	10.13 - 14.27	991,992	2,140,000	21,277
Ironwood Pharmaceuticals Q1 2022 Earnings Preview [5/4/2022 12:14 PM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98M [5/5/2022 7:03 AM] Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance [May-05-22 07:00AM] Ironwood Pharmaceuticals (IRWD) Q1 Earnings Miss Estimates [May-05-22 08:45AM]
17-02-2022	PM	7:15 AM ET (Feb 17)	IRWD	Ironwood Pharmaceuticals, Inc.	1,750	0.27	0.31	0.36	Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96M [2/17/2022 7:11 AM]	10.63	-0.37 (-3.36%)	10.39	-0.61 (-5.55%)	8.78 - 14.27	2,987,201	2,570,000	1,729
Ironwood Pharmaceuticals Q4 2021 Earnings Preview [2/16/2022 12:38 PM] Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96M [2/17/2022 7:11 AM] Medical Stocks' Q4 Earnings on Feb 17: RGEN, IRWD & More [Feb-16-22 09:11AM] Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021 [Feb-17-22 07:00AM]
04-11-2021	PM	7:00 AM ET (Nov 4)	IRWD	Ironwood Pharmaceuticals, Inc.	2,110	0.33	0.31	0.23	Ironwood Pharmaceuticals EPS beats by $0.01, misses on revenue [11/4/2021 7:16 AM]	12.58	-0.27 (-2.10%)	12.58	0.0 (0.00%)	8.78 - 14.27	3,158,005	2,290,000	9,367
Ironwood Pharmaceuticals Q3 2021 Earnings Preview [11/3/2021 9:54 AM] Ironwood Pharmaceuticals EPS beats by $0.01, misses on revenue [11/4/2021 7:16 AM] Ironwood inks collaboration and license option agreement with COUR Pharmaceutical [11/4/2021 7:37 AM] Ironwood Pharmaceuticals Expands Pipeline by Signing an Option Agreement to Acquire an Exclusive License with COUR Pharmaceuticals to Develop and Commercialize CNP-104 for the Treatment of Primary Biliary Cholangitis (PBC) in the U.S. [Nov-04-21 07:00AM] Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update [Nov-04-21 07:15AM] Ironwood Pharmaceuticals (IRWD) Q3 Earnings Surpass Estimates [Nov-04-21 09:55AM] Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call Transcript [Nov-04-21 02:01PM]
05-08-2021	PM	7:00 AM ET (Aug 5)	IRWD	Ironwood Pharmaceuticals, Inc.	2,110	0.34	0.23	0.16	Ironwood Pharmaceuticals EPS beats by $0.12, beats on revenue [8/5/2021 7:06 AM]	13.28	0.34 (2.63%)	13.34	0.40 (3.09%)	8.63 - 13.65	1,456,881	1,780,000	934
Ironwood Pharmaceuticals Q2 2021 Earnings Preview [8/4/2021 10:48 AM] Ironwood Pharmaceuticals EPS beats by $0.12, beats on revenue [8/5/2021 7:06 AM] Why Ironwood (IRWD) Could Beat Earnings Estimates Again [Aug-04-21 12:10PM] Ironwood Pharmaceuticals Reports Strong Second-Quarter 2021 Results, Raises Full-Year Guidance [Aug-05-21 07:00AM] Ironwood Pharmaceuticals, inc (IRWD) Q2 2021 Earnings Call Transcript [Aug-05-21 04:01PM]
06-05-2021	PM	7:00 AM ET (May 6)	IRWD	Ironwood Pharmaceuticals, Inc.	1,750	0.24	0.22	0.04	Ironwood Pharmaceuticals EPS beats by $0.03, misses on revenue; reaffirms guidance [5/6/2021 7:14 AM]	10.49	-0.34 (-3.14%)	10.49	0.0 (0.00%)	8.63 - 12.55	1,940,792	1,520,000	32,547
Ironwood Pharmaceuticals EPS beats by $0.03, misses on revenue; reaffirms guidance [5/6/2021 7:14 AM] Ironwood Pharmaceuticals announces $150M share buyback [5/6/2021 7:43 AM] Deciphera (DCPH) Q1 Loss Narrower Than Expected, Revenues Beat [May-05-21 11:54AM] Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss [May-05-21 11:51AM] Pacira's (PCRX) Q1 Earnings Lag Estimates, Revenues Beat [May-05-21 08:11AM] Ironwood Pharmaceuticals, Inc. to Host Earnings Call [May-06-21 06:30AM] Ironwood Pharmaceuticals Announces New $150 Million Share Repurchase Program [May-06-21 07:03AM] Ironwood Pharmaceuticals (IRWD) Q1 Earnings and Revenues Beat Estimates [May-06-21 09:35AM] United Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat [May-06-21 09:32AM] Ironwood Pharmaceuticals Reports First Quarter 2021 Results [May-06-21 07:00AM] Ironwood Pharmaceuticals Inc (IRWD) Q1 2021 Earnings Call Transcript [May-06-21 02:01PM]
17-02-2021	PM	7:00 AM ET (Feb 17)	IRWD	Ironwood Pharmaceuticals, Inc.	1,600	0.36	0.27	0.30	Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue [2/17/2021 7:04 AM]	9.72	-0.30 (-2.94%)	10.06	0.04 (0.40%)	7.99 - 12.84	1,359,995	1,738,463	4,578
Ironwood Pharmaceuticals EPS beats by $0.07, beats on revenue [2/17/2021 7:04 AM] Ironwood shares rise on Linzess powered fourth-quarter beat [2/17/2021 8:18 AM] Ironwood Pharmaceuticals Inc (IRWD) Q4 2020 Earnings Call Transcript [Feb-17-21 12:00PM] Recap: Ironwood Pharmaceuticals Q4 Earnings [Feb-17-21 07:48AM] Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance [Feb-17-21 07:01AM] Ironwood Pharmaceuticals, Inc. to Host Earnings Call [Feb-17-21 06:30AM]
05-11-2020	AH	4:05 PM ET (Nov 5)	IRWD	Ironwood Pharmaceuticals, Inc.	1,590	0.23	0.14	0.40	Ironwood Pharmaceuticals EPS beats by $0.08, beats on revenue, revised FY20 guidance [11/5/2020 5:53 PM]	10.69	0.68 (6.79%)	11.00	0.99 (9.89%)	7.99 - 14.10	6,881,029	2,116,002	700

06-08-2020	PM	7:00 AM ET (Aug 6)	IRWD	Ironwood Pharmaceuticals, Inc.	1,570	0.16	0.08	0.08	Ironwood Pharmaceuticals EPS beats by $0.06, beats on revenue [8/6/2020 7:36 AM]	10.09	0.45 (4.67%)	9.64	0.0 (0.00%)	7.91 - 14.10	749,019	2,833,879	58,295

06-05-2020	AH		IRWD	Ironwood Pharmaceuticals, Inc.	1,630	0.04	0.11	-0.26		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0